enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Ruxolitinib - Wikipedia

    en.wikipedia.org/wiki/Ruxolitinib

    Ruxolitinib is a Janus kinase inhibitor (JAK inhibitor) with selectivity for subtypes JAK1 and JAK2. [21] [22] Ruxolitinib inhibits dysregulated JAK signaling associated with myelofibrosis. JAK1 and JAK2 recruit signal transducers and activators of transcription (STATs) to cytokine receptors leading to modulation of gene expression. [6]

  3. Janus kinase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Janus_kinase_inhibitor

    A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway in lymphocytes.

  4. Janus kinase - Wikipedia

    en.wikipedia.org/wiki/Janus_kinase

    Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named " just another kinase " 1 and 2 (since they were just two of many discoveries in a PCR -based screen of kinases), [ 1 ] but were ultimately published as "Janus kinase".

  5. New Data for Jakafi® (ruxolitinib) to Be Presented at the ...

    www.aol.com/2012/12/07/new-data-for-jakafi...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Deuruxolitinib - Wikipedia

    en.wikipedia.org/wiki/Deuruxolitinib

    It is a Janus kinase inhibitor selective for JAK1 and JAK2. [2] Although the relative effectiveness of deuruxolitinib and another Janus kinase inhibitor—baricitinib—for alopecia areata may vary depending on the population studied, both drugs are more effective than alternative treatments. [3]

  7. JAK-STAT signaling pathway - Wikipedia

    en.wikipedia.org/wiki/JAK-STAT_signaling_pathway

    The Janus kinase (JAK)/signal transducer and the activator of the transcription pathway were at the centre of attention for driving hyperinflammation in COVID-19, i.e., the SARS-CoV-2 infection triggers hyperinflammation through the JAK/STAT pathway, resulting in the recruitment of dendritic cells, macrophages, and natural killer (NK) cells, as ...

  8. Baricitinib - Wikipedia

    en.wikipedia.org/wiki/Baricitinib

    Baricitinib is a Janus kinase (JAK) inhibitor that reversibly inhibits Janus kinase 1 with a half maximal inhibitory concentration (IC 50) of 5.9 nM and Janus kinase 2 with an IC 50 of 5.7 nM. Tyrosine kinase 2 , which belongs to the same enzyme family, is affected less (IC 50 = 53 nM), and Janus kinase 3 far less (IC 50 > 400 nM).

  9. Dying To Be Free - The Huffington Post

    projects.huffingtonpost.com/projects/dying-to-be...

    For policymakers, denying addicts the best scientifically proven treatment carries no political cost. But there’s a human cost to maintaining a status quo in which perpetual relapse is considered a natural part of a heroin addict’s journey to recovery. Relapse for a heroin addict is no mere setback. It can be deadly.